PCSK9 inhibitor reduced major CVD events in adults with no prior heart attack or stroke
November 08, 2025
November 08, 2025
DALLAS, Texas, Nov. 8 [Category: Health Care] -- The American Heart Association posted the following news release:
* * *
PCSK9 inhibitor reduced major CVD events in adults with no prior heart attack or stroke
*
Research Highlights:
* Results from the international VESALIUS-CV (TIMI 66) clinical trial found that among adults with atherosclerotic cardiovascular disease (ASCVD) or diabetes and no history of a prior heart attack or s . . .
* * *
PCSK9 inhibitor reduced major CVD events in adults with no prior heart attack or stroke
*
Research Highlights:
* Results from the international VESALIUS-CV (TIMI 66) clinical trial found that among adults with atherosclerotic cardiovascular disease (ASCVD) or diabetes and no history of a prior heart attack or s . . .